Electroacupuncture Treatment for Discogenic Low Back Pain

Launched by BEIJING HOSPITAL · Nov 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of electroacupuncture as a treatment for discogenic low back pain (DLBP), a common condition that can cause significant discomfort and affect daily life. The study aims to determine if electroacupuncture can help alleviate pain and improve quality of life for individuals suffering from this type of back pain. Participants will be randomly assigned to receive either real electroacupuncture or a sham (fake) treatment, ensuring that the results will accurately reflect the therapy's effectiveness.

To participate, individuals must be between 18 and 70 years old, have been experiencing moderate to severe low back pain for at least a month, and meet specific health criteria. Throughout the study, participants will undergo a series of 12 treatment sessions over four weeks, followed by follow-up visits to assess their progress. It's important to note that while there may be some minor side effects from acupuncture, the study aims to offer a no-cost treatment option, with all related expenses covered by the researchers. This research could lead to valuable insights for future treatments of low back pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. It meets the diagnostic criteria of discogenic low back pain
• • 2. Betweening 18 and 70 years of age (both 18 and 70) and of either sex
• • 3. Visual analog score (VAS) for low back pain ≥40 mm within the last 1 month
• Exclusion Criteria:
• • 1. Patients with symptoms such as lower limb numbness, weakness and claudication as shown by lumbar disc herniation pressing the spinal nerve on imaging
• • 2. Lumbar tuberculosis, tumor, infection, spinal fracture, lumbar spondylolisthesis, severe osteoporosis
• • 3. Patients with a history of spinal and intervertebral disc surgery
• • 4. Patients with rheumatism, rheumatoid disease, systemic lupus erythematosus, hematopoietic system, endocrine system and psychiatric diseases
• • 5. Patients who have received radiofrequency, minimally invasive, ozone, small needle-knife, acupuncture, manipulation, traction, block therapy and other clinical trials within the last 1 month
• • 6. Patients with severe needle fainting intolerance
• • 7. Women who are pregnant, planning pregnancy or breastfeeding
• • 8. People with a history of opioid analgesics, sedatives and hypnotics and alcohol abuse
• • 9. Patients who plan to undergo acupuncture, massage, traction and other treatments related to this disease and other clinical research trials within 3 months of participating in the study
• • 10. Patients with skin damage or infection, concomitant bleeding tendency, tumor metastasis, serious heart disease, or embedded pacemaker